These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 30245737)

  • 1. Mathematical Analysis of Influenza A Dynamics in the Emergence of Drug Resistance.
    Kanyiri CW; Mark K; Luboobi L
    Comput Math Methods Med; 2018; 2018():2434560. PubMed ID: 30245737
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hedging against antiviral resistance during the next influenza pandemic using small stockpiles of an alternative chemotherapy.
    Wu JT; Leung GM; Lipsitch M; Cooper BS; Riley S
    PLoS Med; 2009 May; 6(5):e1000085. PubMed ID: 19440354
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Emergence of drug resistance during an influenza epidemic: insights from a mathematical model.
    Stilianakis NI; Perelson AS; Hayden FG
    J Infect Dis; 1998 Apr; 177(4):863-73. PubMed ID: 9534957
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Emergence of drug-resistant influenza virus: population dynamical considerations.
    Regoes RR; Bonhoeffer S
    Science; 2006 Apr; 312(5772):389-91. PubMed ID: 16627735
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of different oseltamivir regimens on treating influenza A virus infection and resistance emergence: insights from a modelling study.
    Canini L; Conway JM; Perelson AS; Carrat F
    PLoS Comput Biol; 2014 Apr; 10(4):e1003568. PubMed ID: 24743564
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influenza drug resistance.
    Pizzorno A; Abed Y; Boivin G
    Semin Respir Crit Care Med; 2011 Aug; 32(4):409-22. PubMed ID: 21858746
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Next-Generation Sequencing: An Eye-Opener for the Surveillance of Antiviral Resistance in Influenza.
    Van Poelvoorde LAE; Saelens X; Thomas I; Roosens NH
    Trends Biotechnol; 2020 Apr; 38(4):360-367. PubMed ID: 31810633
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transmission dynamics of an influenza model with vaccination and antiviral treatment.
    Qiu Z; Feng Z
    Bull Math Biol; 2010 Jan; 72(1):1-33. PubMed ID: 19568726
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Emergence of drug resistance: implications for antiviral control of pandemic influenza.
    Alexander ME; Bowman CS; Feng Z; Gardam M; Moghadas SM; Röst G; Wu J; Yan P
    Proc Biol Sci; 2007 Jul; 274(1619):1675-84. PubMed ID: 17507331
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Application of Optimal Control to Influenza Pneumonia Coinfection with Antiviral Resistance.
    Kanyiri CW; Luboobi L; Kimathi M
    Comput Math Methods Med; 2020; 2020():5984095. PubMed ID: 32256682
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intermittent treatment of severe influenza.
    Deecke L; Dobrovolny HM
    J Theor Biol; 2018 Apr; 442():129-138. PubMed ID: 29355540
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The evolution of influenza resistance and treatment.
    Weinstock DM; Zuccotti G
    JAMA; 2009 Mar; 301(10):1066-9. PubMed ID: 19255112
    [No Abstract]   [Full Text] [Related]  

  • 13. Perspectives on antiviral use during pandemic influenza.
    Hayden FG
    Philos Trans R Soc Lond B Biol Sci; 2001 Dec; 356(1416):1877-84. PubMed ID: 11779387
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiviral resistance and the control of pandemic influenza: the roles of stochasticity, evolution and model details.
    Handel A; Longini IM; Antia R
    J Theor Biol; 2009 Jan; 256(1):117-25. PubMed ID: 18952105
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuraminidase inhibitor resistance in influenza: assessing the danger of its generation and spread.
    Handel A; Longini IM; Antia R
    PLoS Comput Biol; 2007 Dec; 3(12):e240. PubMed ID: 18069885
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peptide inhibitors against influenza virus.
    Rajik M; Yusoff K
    Antivir Chem Chemother; 2011 Mar; 21(4):151-4. PubMed ID: 21602612
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oseltamivir PK/PD Modeling and Simulation to Evaluate Treatment Strategies against Influenza-Pneumococcus Coinfection.
    Boianelli A; Sharma-Chawla N; Bruder D; Hernandez-Vargas EA
    Front Cell Infect Microbiol; 2016; 6():60. PubMed ID: 27379214
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinically Relevant Influenza Virus Evolution Reconstituted in a Human Lung Airway-on-a-Chip.
    Si L; Bai H; Oh CY; Jin L; Prantil-Baun R; Ingber DE
    Microbiol Spectr; 2021 Oct; 9(2):e0025721. PubMed ID: 34523991
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuraminidase inhibitor resistance after oseltamivir treatment of acute influenza A and B in children.
    Stephenson I; Democratis J; Lackenby A; McNally T; Smith J; Pareek M; Ellis J; Bermingham A; Nicholson K; Zambon M
    Clin Infect Dis; 2009 Feb; 48(4):389-96. PubMed ID: 19133796
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stochastic model of an influenza epidemic with drug resistance.
    Xu Y; Allen LJ; Perelson AS
    J Theor Biol; 2007 Sep; 248(1):179-93. PubMed ID: 17582443
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.